Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. 2000

L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
Genos Biosciences Incorporated, La Jolla, California 92037, USA.

Treatment of metastatic prostate cancer with androgen-ablation often elicits dramatic tumor regressions, but the response is rarely complete, making clinical recurrence inevitable with time. To gain insight into therapy-related progression, changes in gene expression that occurred following androgen-deprivation of an androgen-dependent prostate tumor xenograft, CWR22, and the emergence of an androgen-independent tumor, CWR22-R, were monitored using microarray analysis. Androgen-deprivation resulted in growth arrest of CWR22 cells, as evidenced by decreased expression of genes encoding cell cycle components and basal cell metabolism, respiration and transcription, and the induced expression of putative negative regulatory genes that may act to sustain cells in a nonproliferative state. Evolution of androgen-independent growth and proliferation, represented by CWR22-R, was associated with a reentry into active cell cycle and the up-regulation of several genes that were expressed at low levels or absent in the androgen-dependent tumor. Androgen repletion to mice bearing androgen-independent CWR22-R tumors induced, augmented, or repressed the expression of a number of genes. Expression of two of these genes, the calcium-binding protein S100P and the FK-506-binding protein FKBP51, was decreased following androgen-deprivation, subsequently reexpressed in CWR22-R at levels comparable with CWR22, and elevated further upon treatment with androgens. The dysregulated behavior of these genes is analogous to other androgen-dependent genes, e.g., prostate-specific antigen and human kallikrein 2, which are commonly reexpressed in androgen-independent disease in the absence of androgens. Other androgen-responsive genes whose expression decreased during androgen-deprivation and whose expression remained decreased in CWR22 were also identified in CWR22-R. These results imply that evolution to androgen-independence is due, in part, to reactivation of the androgen-response pathway in the absence of androgens, but that this reactivation is probably incomplete.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
April 1997, Molecular endocrinology (Baltimore, Md.),
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
January 2002, The American journal of pathology,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
August 2006, The American journal of pathology,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
March 2016, The Prostate,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
November 2002, Cancer research,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
August 2005, Experimental and molecular pathology,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
January 2001, Journal of andrology,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
November 2012, The international journal of biochemistry & cell biology,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
December 1994, Cancer research,
L C Amler, and D B Agus, and C LeDuc, and M L Sapinoso, and W D Fox, and S Kern, and D Lee, and V Wang, and M Leysens, and B Higgins, and J Martin, and W Gerald, and N Dracopoli, and C Cordon-Cardo, and H I Scher, and G M Hampton
December 1998, Cancer research,
Copied contents to your clipboard!